Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Financials ($)
Sales 2014 46,5 M
EBIT 2014 -21,6 M
Net income 2014 -
Debt 2014 -
Yield 2014 -
Sales 2015 44,0 M
EBIT 2015 -21,8 M
Net income 2015 -
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 4,51x
Capi. / Sales 2015 4,77x
Capitalization 210 M
More Financials
Latest news on BIOTA PHARMACEUTICALS INC
02/24 BIOTA PHARMACEUTICALS INC : Biota Pharmaceuticals, Inc. to Present at the 26th A..
02/10 BIOTA PHARMACEUTICALS INC : BIOTA PHARMACEUTICALS, INC. FILES (8-K) Disclosing O..
02/10 BIOTA PHARMACEUTICALS INC : Biota Pharmaceuticals Reports Second Quarter 2013 Fi..
02/03 BIOTA PHARMACEUTICALS INC : Biota Pharmaceuticals to Host Conference Call to Rep..
01/14 BIOTA PHARMACEUTICALS INC : BIOTA PHARMACEUTICALS, INC. FILES (8-K) Disclosing O..
01/14 BIOTA PHARMACEUTICALS INC : Biota Announces Full Exercise of Over-Allotment Opti..
01/13 BIOTA PHARMACEUTICALS INC : Georgia Bio to Honor University, Industry, CDC Leade..
01/10 BIOTA PHARMACEUTICALS INC : BIOTA PHARMACEUTICALS, INC. FILES (8-K) Disclosing E..
01/10 BIOTA PHARMACEUTICALS INC : Biota Prices $25 Million Public Offering
01/09 BIOTA PHARMACEUTICALS INC : BIOTA PHARMACEUTICALS, INC. FILES (8-K) Disclosing O..
01/09 BIOTA PHARMACEUTICALS INC : Biota Announces Proposed Public Offering
2013 BIOTA PHARMACEUTICALS INC : BIOTA PHARMACEUTICALS, INC. FILES (8-K) Disclosing O..
More news
Comments 
Advertisement
Income Statement Evolution
Biota Pharmaceuticals Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF